
Saeid Ebrahimi Dehkordy
Examiner (ID: 10197, Phone: (571)272-7462 , Office: P/2672 )
| Most Active Art Unit | 2672 |
| Art Unit(s) | 2625, 2672, 2626, 2622, 2673 |
| Total Applications | 1284 |
| Issued Applications | 1179 |
| Pending Applications | 4 |
| Abandoned Applications | 108 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18769341
[patent_doc_number] => 20230364099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => SOLID STATE FORMS OF RESMETIROM
[patent_app_type] => utility
[patent_app_number] => 18/029962
[patent_app_country] => US
[patent_app_date] => 2021-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40017
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18029962
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/029962 | Solid state forms of Resmetirom | Oct 18, 2021 | Issued |
Array
(
[id] => 19441361
[patent_doc_number] => 12091602
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-17
[patent_title] => Heteroaryl-thio-substituted pyrones
[patent_app_type] => utility
[patent_app_number] => 17/504307
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8657
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17504307
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/504307 | Heteroaryl-thio-substituted pyrones | Oct 17, 2021 | Issued |
Array
(
[id] => 19656932
[patent_doc_number] => 20240423997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => METHOD OF TREATING AMYOTROPHIC LATERAL SCLEROSIS
[patent_app_type] => utility
[patent_app_number] => 18/700614
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10762
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18700614
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/700614 | METHOD OF TREATING AMYOTROPHIC LATERAL SCLEROSIS | Oct 14, 2021 | Pending |
Array
(
[id] => 18879047
[patent_doc_number] => 20240002416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => MRGPRX4 Agonists and Antagonists
[patent_app_type] => utility
[patent_app_number] => 18/020833
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37092
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 244
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18020833
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/020833 | MRGPRX4 Agonists and Antagonists | Oct 14, 2021 | Pending |
Array
(
[id] => 18567012
[patent_doc_number] => 20230257341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => CIS-PARA-SUBSTITUTED CYCLOHEXYLAMINONITRILE SALT, PREPARATION METHOD THEREFOR AND USE THEREOF, AND METHOD FOR PREPARING PESTICIDE USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/033114
[patent_app_country] => US
[patent_app_date] => 2021-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2272
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18033114
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/033114 | None | Oct 13, 2021 | Issued |
Array
(
[id] => 17774897
[patent_doc_number] => 20220241246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => METHODS OF USE FOR TRISUBSTITUTED BENZOTRIAZOLE DERIVATIVES AS DIHYDROOROTATE OXYGENASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/501701
[patent_app_country] => US
[patent_app_date] => 2021-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15108
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 342
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17501701
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/501701 | Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors | Oct 13, 2021 | Issued |
Array
(
[id] => 17505073
[patent_doc_number] => 20220098175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => DIRECT AMPK ACTIVATORS
[patent_app_type] => utility
[patent_app_number] => 17/500681
[patent_app_country] => US
[patent_app_date] => 2021-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17500681
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/500681 | DIRECT AMPK ACTIVATORS | Oct 12, 2021 | Abandoned |
Array
(
[id] => 18497272
[patent_doc_number] => 20230219884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => PREPARATION METHOD OF ACRYLONITRILE DIMER
[patent_app_type] => utility
[patent_app_number] => 18/008648
[patent_app_country] => US
[patent_app_date] => 2021-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4231
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18008648
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/008648 | PREPARATION METHOD OF ACRYLONITRILE DIMER | Oct 6, 2021 | Pending |
Array
(
[id] => 17342097
[patent_doc_number] => 20220008428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/449131
[patent_app_country] => US
[patent_app_date] => 2021-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24059
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17449131
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/449131 | FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND | Sep 27, 2021 | Abandoned |
Array
(
[id] => 18818817
[patent_doc_number] => 20230393157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => PHOSPHATIDYLALKANOL HOMOLOGUES HAVING LABELLED MOIETIES
[patent_app_type] => utility
[patent_app_number] => 18/044613
[patent_app_country] => US
[patent_app_date] => 2021-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8546
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044613
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/044613 | PHOSPHATIDYLALKANOL HOMOLOGUES HAVING LABELLED MOIETIES | Sep 5, 2021 | Pending |
Array
(
[id] => 19135571
[patent_doc_number] => 11970501
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Highly polarizable 3D organic perovskites and electro-optic materials comprising same
[patent_app_type] => utility
[patent_app_number] => 17/464598
[patent_app_country] => US
[patent_app_date] => 2021-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 32
[patent_no_of_words] => 5574
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17464598
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/464598 | Highly polarizable 3D organic perovskites and electro-optic materials comprising same | Aug 31, 2021 | Issued |
Array
(
[id] => 20634399
[patent_doc_number] => 12595266
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-07
[patent_title] => Pesticidally active heterocyclic derivatives with sulfur containing substituents
[patent_app_type] => utility
[patent_app_number] => 18/043740
[patent_app_country] => US
[patent_app_date] => 2021-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37054
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043740
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043740 | Pesticidally active heterocyclic derivatives with sulfur containing substituents | Aug 31, 2021 | Issued |
Array
(
[id] => 19882991
[patent_doc_number] => 12268673
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Anhydrous compositions of mTOR inhibitors and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/462800
[patent_app_country] => US
[patent_app_date] => 2021-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11331
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 234
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17462800
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/462800 | Anhydrous compositions of mTOR inhibitors and methods of use | Aug 30, 2021 | Issued |
Array
(
[id] => 20730170
[patent_doc_number] => 12637417
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-26
[patent_title] => Method for producing 2-(halogenated methyl)naphthalene and 2-naphthyl acetonitrile
[patent_app_type] => utility
[patent_app_number] => 18/007370
[patent_app_country] => US
[patent_app_date] => 2021-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2915
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007370
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007370 | Method for producing 2-(halogenated methyl)naphthalene and 2-naphthyl acetonitrile | Aug 26, 2021 | Issued |
Array
(
[id] => 17312761
[patent_doc_number] => 20210401809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => PHARMACEUTICAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/411343
[patent_app_country] => US
[patent_app_date] => 2021-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17411343
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/411343 | PHARMACEUTICAL COMPOUNDS | Aug 24, 2021 | Abandoned |
Array
(
[id] => 19896809
[patent_doc_number] => 12274703
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-15
[patent_title] => Compositions and methods of treatment for neurological disorders comprising a dementia
[patent_app_type] => utility
[patent_app_number] => 17/409834
[patent_app_country] => US
[patent_app_date] => 2021-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 27558
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17409834
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/409834 | Compositions and methods of treatment for neurological disorders comprising a dementia | Aug 23, 2021 | Issued |
Array
(
[id] => 18690951
[patent_doc_number] => 20230321123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => INHIBITORS OF PSEUDOMONAS AERUGINOSA VIRULENCE FACTOR LasB
[patent_app_type] => utility
[patent_app_number] => 18/042907
[patent_app_country] => US
[patent_app_date] => 2021-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18307
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042907
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/042907 | INHIBITORS OF PSEUDOMONAS AERUGINOSA VIRULENCE FACTOR LasB | Aug 23, 2021 | Pending |
Array
(
[id] => 17398099
[patent_doc_number] => 20220040189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => COMPOSITIONS AND METHODS OF TREATMENT FOR NEUROLOGICAL DISORDERS COMPRISING MOTOR NEURON DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/409836
[patent_app_country] => US
[patent_app_date] => 2021-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30481
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17409836
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/409836 | Compositions and methods of treatment for neurological disorders comprising motor neuron diseases | Aug 23, 2021 | Issued |
Array
(
[id] => 18692539
[patent_doc_number] => 20230322830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => Novel ruthenium complexes, methods of their preparation and application thereof in olefin cross metathesis
[patent_app_type] => utility
[patent_app_number] => 18/041880
[patent_app_country] => US
[patent_app_date] => 2021-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20635
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 505
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041880
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/041880 | Ruthenium complexes, methods of their preparation and application thereof in olefin cross metathesis | Aug 16, 2021 | Issued |
Array
(
[id] => 20414085
[patent_doc_number] => 12497355
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-16
[patent_title] => Process for preparation of mesotrione and its intermediates
[patent_app_type] => utility
[patent_app_number] => 18/019070
[patent_app_country] => US
[patent_app_date] => 2021-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18019070
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/019070 | Process for preparation of mesotrione and its intermediates | Jul 30, 2021 | Issued |